熊去氧胆酸预防移植后原发性胆汁性胆管炎复发：是时候改变实践了。 - Suppr

UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice.

作者信息

Dyson Jessica K, Jones David E J

机构信息

Translational and Clinical Research Institute, Newcastle University & Liver Unit, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.

出版信息

J Hepatol. 2020 Sep;73(3):499-501. doi: 10.1016/j.jhep.2020.04.040. Epub 2020 Jun 20.

DOI:10.1016/j.jhep.2020.04.040

PMID:32576471

Abstract

摘要

相似文献

UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice.

J Hepatol. 2020 Sep;73(3):499-501. doi: 10.1016/j.jhep.2020.04.040. Epub 2020 Jun 20.

[Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].

Zhonghua Gan Zang Bing Za Zhi. 2019 Jan 20;27(1):73-76. doi: 10.3760/cma.j.issn.1007-3418.2019.01.018.

[Treatment of cholestatic liver diseases with ursodeoxycholic acid].

Tidsskr Nor Laegeforen. 1997 Sep 30;117(23):3370-3.

Obeticholic acid for the treatment of primary biliary cholangitis.

Expert Opin Pharmacother. 2016 Sep;17(13):1809-15. doi: 10.1080/14656566.2016.1218471. Epub 2016 Aug 9.

Liver Transplantation for Primary Biliary Cholangitis.

Clin Liver Dis. 2022 Nov;26(4):765-781. doi: 10.1016/j.cld.2022.06.014.

[Diagnosis and Treatment of Primary Biliary Cholangitis].

Korean J Gastroenterol. 2023 Feb 25;81(2):86-90. doi: 10.4166/kjg.2023.002.

Treatment of Primary Biliary Cholangitis including Transplantation.

Clin Liver Dis. 2024 Feb;28(1):103-114. doi: 10.1016/j.cld.2023.07.003. Epub 2023 Aug 26.

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.

J Hepatol. 2019 Aug;71(2):357-365. doi: 10.1016/j.jhep.2019.04.001. Epub 2019 Apr 11.

Decreased infiltration of CD4 Th1 cells indicates a good response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis.

Pathol Res Pract. 2021 Jan;217:153291. doi: 10.1016/j.prp.2020.153291. Epub 2020 Nov 16.

UDCA, PBC and biochemistry: what does normal mean?

Gut. 2000 Jan;46(1):8. doi: 10.1136/gut.46.1.8.

引用本文的文献

The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms.

Cancers (Basel). 2024 Aug 7;16(16):2789. doi: 10.3390/cancers16162789.

Arbutin Alleviates the Liver Injury of -Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation.

Front Cell Dev Biol. 2021 Dec 2;9:758632. doi: 10.3389/fcell.2021.758632. eCollection 2021.

The Possible Effects of Ursodeoxycholic Acid on Recurrent Primary Biliary Cholangitis and Biliary Complications After Liver Transplant.

Gastroenterol Hepatol (N Y). 2021 Sep;17(9):439-442.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献